Tate Thomas Mason

Tate Mason practices at Stillwater Medical Center in Stillwater, Oklahoma, part of City of Stillwater, Oklahoma.

Tate Mason's NPI, 1225792690, was assigned on October 22, 2021. Tate Mason graduated from Oklahoma State University College of Osteopathic Medicine in 2023. Tate Mason holds Oklahoma license 8604.

Tate Mason's primary practice is Stillwater Medical Center, at 1323 West 6th Street, Stillwater, OK 74076 in Payne County. The practice phone is (405) 372-1480.

Tate Mason's primary practice is Stillwater Medical Center in Stillwater, Oklahoma, part of City of Stillwater, Oklahoma. Tate Mason is also affiliated with Great Plains Regional Medical Center. The medical group on file is Emergency Services Of Oklahoma, PC. Dmand AI also links Tate Mason to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tate Mason practices, 10 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Tate Mason's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Tate Mason is licensed in Oklahoma.

CMS data shows 64 Medicare services from Tate Mason across 3 procedure codes in 2024, for 54 Medicare patients. Medicare paid $6,008 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Tate Mason in 2024. The largest group is 85 and over, with 17 patients. 75% of them have high blood pressure, and 59% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tate Mason's median patient age at 43, with 56% women.

In 2024, Tate Mason wrote 194 Medicare Part D claims for 137 patients. 93% of them were for generic drugs. CMS names the drug for 82 of them, across 4 drugs with 11 or more claims each, at $487 in total drug cost.

Tate Mason accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Tate Mason from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $273.

Tate Mason graduated from Oklahoma State University College of Osteopathic Medicine in 2023.